Latest News and Press Releases
Want to stay updated on the latest news?
-
SAN DIEGO, Oct. 15, 2013 (GLOBE NEWSWIRE) -- Given Imaging (Nasdaq:GIVN), a world leader in specialty GI products and pioneer of capsule endoscopy, today announced new studies validating PillCam SB's...
-
BERLIN, Oct. 15, 2013 (GLOBE NEWSWIRE) -- Given Imaging Ltd, (Nasdaq:GIVN), a world leader in gastrointestinal medical devices and pioneer of capsule endoscopy, today announced results from four...
-
SAN DIEGO, Oct. 14, 2013 (GLOBE NEWSWIRE) -- Given Imaging Ltd, (Nasdaq:GIVN), a world leader in GI medical devices and pioneer of capsule endoscopy, today announced results from two new studies that...
-
- Ten abstracts including more than 1,200 patients to be presented on PillCam COLON - - Topics range from confirming the diagnostic yield of PillCam COLON and validating feasibility of...
-
YOQNEAM, Israel, Oct. 10, 2013 (GLOBE NEWSWIRE) -- Given Imaging Ltd, (Nasdaq:GIVN), a world leader in gastrointestinal medical devices and pioneer of capsule endoscopy, today announced that more than...
-
YOQNEAM, Israel, Oct. 9, 2013 (GLOBE NEWSWIRE) -- Given Imaging Ltd. (Nasdaq:GIVN) today announced the results of a special shareholders' meeting which was held yesterday in Yoqneam, Israel. A total...
-
YOQNEAM, Israel, Sept. 23, 2013 (GLOBE NEWSWIRE) -- Given Imaging Ltd, (Nasdaq:GIVN), a world leader in gastrointestinal medical devices and pioneer of capsule endoscopy, today announced that Japan's...
-
YOQNEAM, Israel, Aug. 28, 2013 (GLOBE NEWSWIRE) -- Given Imaging (Nasdaq:GIVN) today announced that Homi Shamir, President and CEO, will present at the Morgan Stanley Global Healthcare Conference...
-
YOQNEAM, Israel, Aug. 13, 2013 (GLOBE NEWSWIRE) -- Given Imaging Ltd, (Nasdaq:GIVN), a world leader in GI medical devices and the pioneer of capsule endoscopy, today announced that the United States...
-
- Record Second Quarter 2013 Revenues Increase 11% to $49.5 million – - Company Achieves Record Sales of 62,700 PillCam SB Capsules in Second Quarter 2013 – - Second...